Skip to content

BIOVER

Absorbed by Perrigo Belgium KBO/BCE: BE 0428.014.874 subsidiary of Perrigo Company PLC

Lifetime

18 annual accounts with figures on one time axis, 38 filings since 1986
peak €18.0m (2013)
€3.4m▼ 65.5%
lowest -€1.6m (2015)
€734,845▲ 102×
peak €33.6m (2013)
€7.9m▲ 10.2%
€2.6m▼ 10.5%
peak 27.6 FTE (2012)
0.8 FTE▼ 60.0%
Board8 names since 2016
3 directorsMira De Maeyer and 2 others
Owners4 names in the annual accounts
100%Perrigo Belgium and 1 other
Documentsfilings and deeds
27-05-202465 days before the deadline
2023financial year
Turnover from €9.9m to €3.4mResult from €7,190 to €734,845Staff from 2 FTE to 0.8 FTEAmendment of the articles 25-07Resignation: Anrie Waelkens (director) 13-03Resignation: Anne Waelkens (director) 08-03

Key points

from the 2023 annual accounts, the last ones filed

Equity

€7.9m from €33.6m in 2013

Equity fell by 76% in 10 years.

Staff

0.8 FTE from 27.6 in 2012

Between 2012 and 2023, 97% of the full-time equivalents disappeared.

Payment terms

45 days to suppliers
Suppliers
113 to 45
Customers
104 to 35

BIOVER pays its suppliers 68 days earlier than in 2022. Customers pay 69 days earlier.

No scoreTurnover -66%: absorbed

Board and ownership

MD
Managing director
CV
Director, since 06-12-2022
AV
Director, since 01-01-2024
EB
Auditor, BV Paul Eelen
Board & ownership

Recent changes

Merger: absorbed by PERRIGO BELGIUM General meeting of 19-06-2024 · Gazette deed
Reappointment: EY Bedrijfsrevisoren (statutory auditor) Permanent representative: Paul Eelen · General meeting of 13-05-2024 · Gazette deed
Merger proposal: to be absorbed by Perrigo Belgium Perrigo Belgium holds all the shares · Gazette deed
1 director appointed, 1 resignation Resignation: Pachtersbos BV · Permanent representative: Lieven Costers · Appointment: Anja van Winsberghe · General meeting of 18-12-2023 · Gazette deed
All 57 events

Official details

Source: KBO
Status
Absorbed by Perrigo Belgiummerger by absorption, June 2024
Activity
“De handel onder al zijn vormen (groot- en kleinhandel, aan- en verkoop, import en…” (deed in Dutch)From the articles, 32 activitiesNo NACE code in the KBO yet
Joint committees
116Chemical industry
207White-collar workers in the chemical industry · annual accounts 2023
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2023

€10.5m▲ 4.3%
Filing
Filed on 27-05-2024
Financials

Insights on BIOVER

BIOVER reached its highest turnover since 2006 in 2013: €18.0m. A year later it was €15.3m, and in 2015 still €14.0m.

Equity fell from €33.6m in 2013 to €7.9m in 2023.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIOVER

What is the company number of BIOVER?
The company number of BIOVER is 0428.014.874. The VAT number is the same number with BE in front: BE 0428.014.874.
What is the legal form of BIOVER?
Legal form of BIOVER: NV.
Is BIOVER still active?
No. BIOVER is inactive in the KBO register.Company details
How many employees did BIOVER have?
BIOVER had an average of 0.8 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
Which joint committee does BIOVER fall under?
In its 2023 annual accounts, BIOVER states joint committees 116 (Chemical industry) and 207 (White-collar workers in the chemical industry).
What is the turnover of BIOVER?
The turnover of BIOVER was €3.4m in financial year 2023, according to the filed annual accounts.
Is BIOVER profitable?
In financial year 2023, BIOVER made a profit of €734,845.
Where can I find the annual accounts of BIOVER?
BIOVER filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2023.

Next steps

Keep this company with today's facts in a case file.